Confirmed in the announcement today preliminary results expected in April
Clinical update for Phase 2a/b PROTECT clinical trial utilising ISLA-101 to combat dengue fever expected in April prior to full results
Ann: ISLA-101 shows anti-dengue activity in Phase 2a readout, page-139
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.010(6.06%) |
Mkt cap ! $35.41M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 15.0¢ | $117.7K | 740.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 74539 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 17104 | 2 |
View Market Depth
| Last trade - 14.09pm 17/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |